Bristow M R, Green R D
Eur J Pharmacol. 1977 Oct 1;45(3):267-79. doi: 10.1016/0014-2999(77)90009-7.
The effect of diazoxide, verapamil and compound D600 on calcium and isoproterenol dose-response relationships was investigated in isolated rabbit atrial preparations. All three agents shifted calcium dose-force relationships parallel and to the right. D600 acted as a competitive antagonist of calcium, as a plot of log (x - 1) vs. -log B resulted in a straight line with a slope of approximately -1.0. Diazoxide, verapamil and D600 also antagonized isoproterenol but in a non-competitive manner. A reduction of calcium in the bathing fluid produced a qualitatively similar non-competitive antagonism of isoproterenol and markedly potentiated diazoxide antagonism of isoproterenol. We conclude that: (1) diazoxide has calcium antagonistic properties similar to the "calcium antagonists" verapamil and D600; (2) these agents act as competitive antagonists of calcium through a specific site that is beyond the beta-adrenergic receptor and in the series of events between the beta-adrenergic receptors and inotropic response in myocardial tissue.
在离体兔心房标本中研究了二氮嗪、维拉帕米和复方D600对钙和异丙肾上腺素剂量-反应关系的影响。这三种药物均使钙剂量-力关系平行右移。D600作为钙的竞争性拮抗剂,log(x - 1)对-log B作图得到一条斜率约为-1.0的直线。二氮嗪、维拉帕米和D600也拮抗异丙肾上腺素,但呈非竞争性。浴液中钙减少产生了性质相似的异丙肾上腺素非竞争性拮抗作用,并显著增强了二氮嗪对异丙肾上腺素的拮抗作用。我们得出结论:(1)二氮嗪具有与“钙拮抗剂”维拉帕米和D600相似的钙拮抗特性;(2)这些药物通过一个位于β-肾上腺素能受体之外且在心肌组织中β-肾上腺素能受体与变力反应之间一系列事件中的特定位点,作为钙的竞争性拮抗剂发挥作用。